Clinical Trial Update: Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRC [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a hybrid and fully automated closed-loop artificial pancreas device is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: Dose Safety Inc. | Conditions: Glucose, Low Blood, Glucose, High Blood | Phase 1, Phase 2 | Status: SUSPENDED